NDC 0404-9825
Brevibloc 10 mg per 1 mL injection
On the label: Henry Schein, Inc.. It's repackaged: Henry Schein, Inc. rebottles it from Baxter Healthcare Corporation's NDC 10019-115.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Baxter Healthcare Corporation | Marion, NC, United States | Makes it, tests it, packages it, labels it and sterilizes it | Serious problems, FDA actionFeb 9, 2024 · 9 inspections, 3 with FDA action |
| Syngene International Limited | Bengaluru, India | Tests it | No problems foundFeb 20, 2025 · 4 inspections |
Recalls
- Apr 12, 2016 · Class II · Baxter Healthcare Corp.
Discoloration: presence of atypical yellow discoloration of the solution .
Lots: Lot # C989954, Exp 9/17 - Jun 16, 2014 · Class II · Baxter Healthcare Corp.
Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.
Lots: Lot #: C926923, Exp 01/16
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Esmolol: every company that makes it
- Form
- injection, intravenous
- Strength
- 10 mg per 1 mL
- Approval
- NDA NDA019386
- On the market since
- Jan 9, 2022
- Package NDCs
0404-9825-10- Official label
- DailyMed (National Library of Medicine), updated Aug 6, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?